2 recruiting. 2 Phase 2, 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Recruiting 2 |
| Phase 3 | 2 | Recruiting 2 |
Follow Peter Black: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| NEO-BLAST: Neoadjuvant Therapy for Bladder Cancer Followed by Active Surveillance vs Treatment Active Surveillance, Control arm - Definitive bladder treatment - Muscle-Invasive Bladder Carcinoma | Phase 2 / Phase 3 | Recruiting | Peter Black | 688 | 2025-07-28 | 2025-07-30 |
| Multicenter Clinical Trial of ST-02 for Ablation of Upper Tract Urothelial Carcinoma ST-02 - Urothelial Carcinoma of the Renal Pelvis and Ureter, Transitional Cell Cancer of the Renal Pelvis and Ureter | Phase 2 / Phase 3 | Recruiting | Peter Black | 70 | 2024-06-19 | 2026-08-03 |
Circulating Tumor DNA (1) · Magnetic Resonance Spectroscopy (1) · Transurethral Resection of Bladder (1) · Watchful Waiting (1)
Canada (2)
Marie-Pier St-Laurent, Dr. (1)